ESR1 and breast carcinoma: 14 exhibits potent degradation of ER in MCF-7 breast cancer cells (IC50 = 1.53 nM) and efficiently inhibits MCF-7 cell proliferation (IC50 = 2.56 nM) in vitro assays.